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and rosuvastatin. His family history was unremarkable, notably with
no atherosclerotic disease and no consanguinity. Hismedical history re-
vealed pain in several small joints of the hands, knees, and ankles since
1994, without rheumatological diagnosis.
Physical examination showed absent pulsations of the dorsal pedal
arteries on both feet. Laboratory examination revealed normal serumDear Editor
A forty-two year oldmanwas referred to the Dept. of Vascular Med-
icine because of severe intermittent claudication of both legs, that
started at the age of 27. He never smoked, used alcohol in moderatione, Division of Vascular Medicine 46
en).
slide (b) of the upper leg demonstrat
land Ltd. This is an open access articland didn't use illicit drugs. His medication included acetylsalicylic acid
concentration of total cholesterol (3.2 mmol/l), creatinine (71 μmol/l),
glucose (5.3 mmol/l), calcium (2.41 mmol/l), inorganic phosphate
(0.99 mmol/l), parathyroid hormone (4.3 pmol/l), and 25-OH-vitamin
D (56 μmol/l).
A CT angiography of the thorax and abdomen was performed in
2007 revealing extensive arterial lower limb calciﬁcations starting
from the femoral artery (Fig. 1). Remarkably, the aorta and coronary3, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 GA Nijmegen,
ing extensive calciﬁcations in the wall of the superﬁcial femoral artery.
e under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 2. X-ray of the hands demonstrating small periarticular calciﬁcations (see arrows).
249Correspondencecirculation were free from calciﬁcations. Conventional X-ray of his
hands revealed extensive pericapsular calciﬁcations of the small hand
joints (Fig. 2).
Based on the combination of extensive isolated lower limb calci-
ﬁcations and small joint calciﬁcation, the patient was subsequently
referred to the Dept. of Human Genetics and a genetic screening of
the NT5E gene was proposed after informed consent.
Sanger sequencing of the 9 exons and exon–intron boundaries
of the NT5E gene (NM_002526.3) was performed as describedFig. 3.Gel electrophoresis (a) and Sanger electropherogram (b) of theNT5E cDNA exons 2 to 4 fr
corresponds to complete homozygous skipping of exon 3 (3b).elsewhere [1], and a novel homozygous splice-site variation of in-
tron 3 was identiﬁed (c.751 + 2 TNC). This variation was predicted
to abolish splicing by four bioinformatics tools (MAxEntScan,
NNSPLICE, GeneSplicer, and Human Splicing Finder). After skin bi-
opsy and ﬁbroblast culture, RNA was extracted and RTPCR, gel elec-
trophoresis and Sanger sequencing revealed total in-frame skipping
of exon 3 (Fig. 3), with no minor transcripts, compared to control
cDNA of an unaffected individual.
The clinical picture of arterial calciﬁcation of the lower extrem-
ities and joint calciﬁcations has been described as early as 1914
and an inherited nature of this disease was suggested in 1954
(CALciﬁcation of Joints and Arteries; CALJA; #211800) [2]. In our
patient, the typical distribution of the vascular calciﬁcations
in combination with the small joint calciﬁcation, suggested a
recessive defect in the NT5E gene, as previously described in
three families with CALJA [1]. NT5E encodes CD73, which is a
membrane-bound ecto-5′-nucleotidase catalyzing the conversion
of AMP to adenosine [3]. It is hypothesized that adenosine acts
as a natural break on tissue calciﬁcation by inhibiting tissue-
nonspeciﬁc alkaline phosphatase which degrades pyrophosphate,
a potent tissue calciﬁcation inhibitor. Recently, the phenotype
was extended to upper limb arterial calciﬁcations, raising the
question of phenotypic spectrum in CALJA [4]. Bisphosphonates,
which are pyrophosphate analogs and potent inhibitors of tissue
calciﬁcation, might prove beneﬁcial in patients with NT5E muta-
tions, which is currently under investigation (ClinicalTrails.gov
Identiﬁer: NCT01585402).Conﬂict of interest
None.om thepatient'sﬁbroblast culture compared to anunaffected control. The 300 bpband (3a)
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